{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-016681","form_type":"8-K","ticker":"EXOZ","cik":"0002010788","company_name":"EXOZYMES INC.","filed_at":"2025-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.678397+00:00","generated_at":"2026-05-18T18:32:04.327731+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"eXoZymes to receive $3M from NSF as key partner in $9.2M cell-free biomanufacturing initiative","bullets":["Selected as core industrial partner in Meta-PURE, a $9.2M NSF-funded project under CFIRE program.","eXoZymes awarded approximately $3M share to develop a cell-free ATP-generating module and a santalene production module.","Project led by Georgia Tech; coalition includes academic and industry groups; starts July 1, 2025, for three years.","eXoZymes' technology enables plug-and-play modular cell-free biomanufacturing for multiple market-relevant targets."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-016681","json":"https://secwatch.observer/filing/0001641172-25-016681.json","markdown":"https://secwatch.observer/filing/0001641172-25-016681.md","text":"https://secwatch.observer/filing/0001641172-25-016681.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2010788/000164117225016681/0001641172-25-016681-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2010788/000164117225016681/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T18:32:04.327731+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}